cannabis international 

Cannabis-International is a Biopharmaceutical company working to produce medical cannabis to a wide range of patient groups. The company was founded in 2018 with the purpose to contribute to making a better life quality for the patients. Cannabis-International is approved by the Danish Medicines Agency for cultivation and handling of medical cannabis. The trademark of Cannabis-International is a strict focus on quality, safety and consistency in all processes related to producing Active Pharmaceutical Ingredients (API’s).

PILOT PROGRAM

On the 1st of January 2018 a pilot program allowing doctors to prescribe a new kind of medicinal cannabis which haven’t previously been legal in Denmark was put into place. The objective of the pilot program is to offer patients who haven’t benefitted from traditional products a legal option to try a treatment with medicinal cannabis. The intention of the pilot program is to provide a better basis for evaluating the use of medicinal cannabis once the program ends. (Danish Medicines Agency)

QUALITY CONTROL

The standards in Denmark for manufacturing medicine is controlled by the Danish Medicines Agency. All companies that produces medicinal products will have to be compliant with all manufacturing regulations. Denmark is known for having high regulated standards, which is the reason for our uniformed and high-quality products. The Danish Medicines Agency and the Danish Agricultural Agency is working to ensure that the production will follow the best conditions. All companies will be inspected and controlled before and after they can release Active Pharmaceutical Ingredients to the market.